Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FET PET Imaging in Recurrent GBM Patients Receiving Avastin
NCT01756352Phase 2Completed
- Sponsor
- Marcelo F. Di Carli
- Start
- Feb 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of O-(2-[18F]fluoroethyl)-L-tyrosine in glioblastoma multiforme (GBM), sponsored by Marcelo F. Di Carli. Started Feb 2013; status: completed.
02
Drugs
O-(2-[18F]fluoroethyl)-L-tyrosine
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01756352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756352.